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Because the clinical improvement occurred only after the wash-out time of nifedipine, we concluded that nifedipine was the cause of this life-threatening state. The mechanism of these adverse effects seems to be either a negative cardiac inotropic effect or a modification of capillary blood flow, like that described in peripheral oedema caused by the dihydropyridines3 or a combination of both mechanisms. 
